Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TICAGRELOR
- Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIA
- Ticagrelor Versus Clopidogrel in Large Vessel Ischemic Stroke
- Effects of Cangrelor on MIcRovAscular Disfunction During Elective Percutaneous CORonary Intervention
- Ticagrelor Single Antiplatelet Therapy in Patients With High Risk of Bleeding After DCB for Coronary Small Vessel Disease
- Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus
- De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent ACS
- Ticagrelor vs. Clopidogrel in Post PCI Patients
- De-escalation of Ticagrelor in Post PPCI
- Prasugrel Or Ticagrelor De-escalation in NSTE-ACS
- Pharmacodynamic Outcomes in CCS Patients Treated With an Individualized Treatment Strategy
- Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI
- Effects of Ticagrelor Versus Prasugrel on Coronary Microcirculation in Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the PROtecting MICROcirculation During Coronary Angioplasty (PROMICRO)-3 Randomised Study
- Apixaban vs Dual Antiplatet Therapy Study After Left Atrial Appendage Occlosure (ADALA)
- Ticagrelor Versus Clopidogrel in Ischemic Stroke
- Impact of CYP2C19 Genotype-guided Clopidogrel and Ticagrelor Treatment on Platelet Function Test and Metabolomics Profile
- Polypill in Acute Coronary Syndrome
- EVALUATION OF LOW DOSE COLCHICINE AND TICAGRELOR IN PREVENTION OF ISCHEMIC STROKE IN PATIENTS WITH STROKE DUE TO ATHEROSCLEROSIS
- Testing P2Y12 Platelet Inhibitors Generics Beyond Bioequivalence
- Tailored Versus Coventional AntiPlaTelet Strategy Intended After OPTIMIZEd Drug Eluting Stent
- Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting
- KF2019#1-trial: Effects of a Thrombocyte Inhibitor on a Cholesterol-lowering Drug
- GM03 - Platelet RNA Signatures of Aspirin
- Platelet Aggregation and Adenosine Levels Among Patients Taking Ticagrelor or Prasugrel
- Optimal Dosage of Ticagrelor in Korean Patients With AMI
- Paclitaxel-Coated Balloon Versus Zotarolimus-Eluting Stent for Treatment of De Novo Coronary Artery Lesions
- Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome
- Dual Antiplatelet Therapy in Patients With Clopidogrel Resistance Following Off-Pump Coronary Artery Bypass
- Study to Evaluate the Safety, Tolerability, PK, and PD of PB2452 With and Without Ticagrelor Pretreatment in Chinese Healthy Volunteers
- Ticagrelor Monotherapy After Stenting
- Acetyl Salicylic Elimination Trial JAPAN: The ASET JAPAN Pilot Study
- Differential EFfects of Dual antIplatelet and Dual aNtithrombotic thErapy on Hemostasis in Chronic Coronary Syndrome Patients
- A Study to Evaluate BMS-986141 Added on to Aspirin or Ticagrelor or the Combination, on Thrombus Formation in a Thrombosis Chamber Model in Participants With Stable Coronary Artery Disease and Healthy Participants
- CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 4
- Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
- The Effect of Early Administration of Dapagliflozin in STEMI Patients With LV Systolic Dysfunction
- Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System
- Effectiveness of Combined Anticoagulation and Antithrombotic Therapy vs Antithrombotic Therapy Alone After Lower Extremity Revascularization for Peripheral Arterial Disease
- 24-month Ticagrelor-based Dual-antiplatelet Therapy Versus Clopidogrel-based Dual-antiplatelet theRapy aftEr 12 Months of DrUg-eluting Stent Implantation in High isChEmic Risk Patients: P-REDUCE Trial
- 1-month DAPT Plus 5-month Ticagrelor Monotherapy Versus 12-month DAPT in Patients With Drug-coated Balloon
- Comparison of the Efficacy of Ticagrelor Combined With ASA to ASA Alone in Patients With Stroke
- Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II
- Mono Antiplatelet and Colchicine Therapy
- Ticagrelor in Post-transplant Patients With Pediatric Hepatic Artery Thrombosis (HAT)
- To Evaluate the Safety and Tolerability of Combined Administration of SHR2285 Tablets With Aspirin, Clopidogrel or Ticagrelor in Healthy Subjects
- Bioequivalence Study of Anplag® 90mg (Ticagrelor) Tablet & Brilinta® 90 mg (Ticagrelor) Tablet in Healthy Adult Male Pakistani Subjects Under Fasting Condition
- MonotherApy of Low-does TicagrElor After Percutaneous Coronary Intervention
- Evaluation of Myocardial Reperfusion After Primary PCI in Patients With High Platelet Reactivity Treated by Cangrelor or Not
- Ticagrelor De-escalation Strategy in East Asian Patients With AMI
- Effect of Upstream Treatment With High Intensity Statin on the Outcomes of STMI Patients Treated With PPCI
- Platelet Inhibition With Ticagrelor 60 mg Versus Ticagrelor 90 mg in Elderly Patients With ACS
- Efficacy of Ticagrelor Plus Aspirin in Minor Non-cardioembolic Ischemic Stroke
- Prasugrel 5 mg vs. Ticagrelor 60 mg in CHIP (E5TION)
- The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients
- Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome
- Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI
- Dual Therapy With Dabigatran/Ticagrelor Versus Dual Therapy With Dabigatran/Clopidogrel in ACS Patients With Indication for NOAC Undergoing PCI
- VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome
- PD and PK Profiles of Switching Between Cangrelor and Ticagrelor Following Ticagrelor Pre-treatment
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese Subjects
- 3 Months Versus 12 Months Dual Antiplatelet Therapy After Drug-eluting Stent Implantation in STEMI
- Pharmacodynamic Evaluation of Antiplatelet Effect of Swallowing Versus Chewing Ticagrelor in Patients With Acute Coronary Syndrome
- Paclitaxel-coated Balloon for Treatment of De-novo Non-complex Coronary Artery Lesions
- Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE
- Ticagrelor With and Without Aspirin in Patients With Diabetes Mellitus
- Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After PCI
- ANalgesic Efficacy and Safety of MOrphiNe Versus Methoxyflurane in Patients With Acute Myocardial Infarction
- Influence of METHoxyflurane on ANtiplatelet Effect of Ticagrelor in Patients With Unstable Angina Pectoris
- Atorvastatin Effect on Contrast Induced Nephropathy in Diabetic Patients Undergoing Elective Coronary Intervention
- Efficacy and Safety of Individualized P2Y12 Receptor Antagonists Treatment Based on Agregometry Versus Fixed Dose Regimen in Patients After Acute Myocardial Infarction
- Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE
- Platelet REACtivity According to TICagrelor Dose After Transcatheter AorticValve Implantation
- A sTudy of Low Dose vs Standard Dose of tIcaGrelor on Platelet Function After intErvention for Acute Coronary syndRome in Diabetes Mellitus Patients
- A Study of Low Dose vs Standard Ticagrelor on Platelet Function After Intervention for Acute Coronary Syndrome in Senior Patients
- Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing Vaso-Occlusive Crises Rate in Pediatric Patients With Sickle Cell Disease.
- Bentracimab (PB2452) in Ticagrelor-treated Patients With Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure
- A Study of Low and Standard-dose Ticagrelor After Intervention for ACS Patients
- Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention
- The Effects of loW Dose tIcagrelor on Platelet Function Testing in Patients With Stable Coronary arTery Disease
- Ticagrelor in Remote Ischemic Preconditioning Study
- Personalized Vs. Standard Duration of Dual Antiplatelet Therapy and New-generation Polymer-Free vs- Biodegradable-Polymer DES
- Phase 2B Study to Evaluate the Efficacy of PB2452 in Reversal of Ticagrelor in Subjects Aged 50-80 Years Old
- OPTImal Management of Antithrombotic Agents: OPTIMA-5
- Safety and Effectiveness of Ticagrelor in Patients Undergoing Carotid Stenting
- Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II
- Study in Diabetes Mellitus Patients Without Prior Myocardial Infarction or Stroke Undergoing Elective Percutaneous Coronary Intervention.
- LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
- Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
- DUAL Antithrombotic Therapy in Patients With AF and ACS
- The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions
- Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
- Cangrelor in Comatose Survivors of OHCA Undergoing Primary PCI
- Ticagrelor and Clopidogrel on Platelet Effects in Chinese Patients With Stable Coronary Artery Disease
- 1-month vs 12-month DAPT for ACS Patients Who Underwent PCI Stratified by IVUS: IVUS-ACS and ULTIMATE-DAPT Trials
- Study to Evaluate the Safety, Tolerability, PK and PD of PB2452 in Healthy Younger, Older and Elderly Subjects
- Proton Pump Inhibitor Preventing Upper Gastrointestinal Injury In Patients On Dual Antiplatelet Therapy After CABG
- Ticagrelol Versus Aspirin in Ischemic Stroke
- Ticagrelor Monotherapy Compared to Aspirin Monotherapy in Patients With History of ACS
- The Impact of Aspirin Dose Modification on the Innate Immune Response - Will Lower Dose Aspirin Therapy Reduce the Response to Endotoxin
- Ticagrelor Administered as Standard Tablet or Orodispersible Formulation
- Ticagrelor Monotherapy in PAtients Treated With New-generation Drug-eluting Stents for Acute Coronary Syndrome; T-PASS Trial
- SAPT Versus DAPT in Incomplete Revascularization After CABG
- Personalization of Long-Term Antiplatelet Therapy - RAPID EXTEND
- Chewed Versus Integral Pill of Ticagrelor
- Low-dose of Ticagrelor and Standard-dose Clopidogrel on Platelet Effects in Chinese Patients With Stable CAD.
- Chronic Kidney Disease (CKD) Platelet Study
- Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent Implantation
- Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell Disease
- Ticagrelor and Clopidogrel on Platelet Aggregation in Clopidogrel Resistance's Patients With CHD
- SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance to Examine the Safety of Cessation of Dual Anti-Platelet Therapy in High Bleeding Risk Patients at One Month
- Trimetazidine as an Adjunct to Enhance Clopidogrel Response.
- The Optimal Strategy of Switching From Clopidogrel to Ticagrelor in Patients With Complexity of Coronary Artery Disease
- Ticagrelor and ASA vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patients With Acute Coronary Syndrome
- Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction
- PK Study of Ticagrelor in Children Aged Less Than 24 Months, With Sickle Cell Disease (HESTIA4)
- Study to Evaluate the Safety, Tolerability, PK, and PD of PB2452 in Healthy Volunteers
- Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-function: a Validation Study
- A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Heart Attack
- Fentanyl and Crushed Ticagrelor in Percutaneous Coronary Intervention
- Individualized Antithrombotic Therapy for Patients With Ischemic Cerebrovascular Disease
- TAILored Versus COnventional AntithRombotic StratEgy IntenDed for Complex HIgh-Risk PCI
- Daily Variability of Platelet Aggregation in Patients With Myocardial Infarction Treated With Prasugrel and Ticagrelor
- A Study of the Effect of Epinephrine on Platelet Reactivity in Subjects Treated With Ticagrelor
- Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCI
- Prasugrel vs. Ticagrelor on Myocardial Injury in STEMI
- A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Healthy Subjects
- Optimized Antithrombotic Therapy of Acute Myocardial Infarction With Left Ventricular Mural Thrombus
- The Effect of Opioids on P2Y12 Receptor Inhibition in Patients With ST-Elevation Myocardial Infarction Who Are Pre-treated With Crushed Ticagrelor
- Low Dose Ticagrelor Versus Low Dose Prasugrel in Patients With Prior Myocardial Infarction
- Low-dose Ticagrelor in Chinese ACS Patients Undergoing PCI
- Efficacy and Safety of Low-dose Ticagrelor
- The Effect of Glucocorticoid Therapy on Left Ventricular Remodelling in Acute Myocardial Infarction (RECONSIDER)
- Safety and Efficacy of LMWH Versus Rivaroxaban in Chinese Patients Hospitalized With Acute Coronary Syndrome
- TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome.
- THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death
- The Safety and Efficacy Of Rivaroxaban and Ticagrelor for Patients With Atrial Fibrillation After Percutaneous Coronary Intervention
- Add-on Cangrelor in STEMI-triggered Cardiac Arrest
- Effectiveness of Lower Maintenance Dose of Ticagrelor Early After Myocardial Infarction (ELECTRA) Pilot Study
- Platelet Inhibition With Cangrelor and Crushed Ticagrelor in STEMI
- Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4)
- A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)
- Downstream Molecular Signals of P2Y12 Receptors in Hyporeactive Patients Under Clopidogrel Treatment A Possible Mechanism of HOTPR(High On-Treatment Platelet Reactivity)
- Cangrelor vs. Ticagrelor for Early Platelet Inhibition in STEMI
- CES1 Crossover Trial of Clopidogrel and Ticagrelor
- Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD
- Prolonged Enoxaparin In Primary Percutaneous Coronary Intervention; A Pilot Pharmacodynamic Study
- A Study to Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are Administered
- P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold
- Study of AggreGuide A-100 (ADP) Assay
- Platelet Inhibition to Target Reperfusion Injury
- Ticagrelor Versus High-dose Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After PCI
- Half-dose Ticagrelor Overcomes High-dose Clopidogrel in Acute Coronary Syndrome Patients With High On-Clopidogrel Platelet Reactivity
- Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor
- A Single Center Study to Evaluate Ticagrelor Mechanism of Action in Inhibiting Juvenile Platelet ADP Response
- Chewing Ticagrelor Versus Prasugrel in ST-elevation Myocardial Infarction - A Platelet Reactivity Study
- Reversal of the Antiplatelet Effects of Ticagrelor in Combination With Aspirin, Using Normal Platelets
- A Trial to Assess the Safety and Efficacy of Prophylactic TicagrelOr With Acetylsalicylic Acid Versus CLopidogrel With Acetylsalicylic Acid in the Development of Cerebrovascular EMbolic Events During TAVI
- Randomized Comparison of Cangrelor, Tirofiban and Prasugrel in Patients With STEMI Referred for Primary PCI.
- Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR)
- Cangrelor Following Ticagrelor Loading vs Ticagrelor Loading Alone in STEMI
- Methylnaltrexone as a Method to Improve Ticagrelor Uptake in Morphine Treated STEMI Patients
- Influence of Naloxone on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine
- Influence of Metoclopramide on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine
- Antiplatelet Therapy Effect on Extracellular Vesicles in Acute Myocardial Infarction
- Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate in STEMI Patients
- Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel
- Effects of Morphine on Loading-dose Ticagrelor in Patients With ST-segment Elevation Myocardial Infarction
- The Effect of Ticagrelor With or Without Atorvastatin on Endothelial Function in Healthy Males
- Effects of Different Doses of Ticagrelor on Platelet Aggregation and Endothelial Function in Diabetic Patients With Stable Coronary Artery Disease
- Ticagrelor in Methotrexate-Resistant Rheumatoid Arthritis
- Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
- Polypectomy in Patients Taking Dual Antiplatelet Agents
- Effect of Second-look Endoscopy on Peptic Ulcer Rebleeding in Patients With Early Resumption of Antiplatelet Agents
- Safety Profile Evaluation of TICagrelor Alone Compared to a Combination of Lysine Acetylsalicylate-Clopidogrel in the Context of Transcatheter Aortic Valve Implantation (TAVI)
- Comparison of Prasugrel and Ticagrelor in the Treatment of Acute Myocardial Infarction
- Effects of Ticagrelor on No-reflow in Patients With Acute ST-segment Elevation Myocardial Infarction
- Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With STEMI Undergoing Primary PCI
- Post-operative Treatment of Diabetic Peripheral Arterial Disease Guided by Platelet Reactivity Unit
- Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention
- Clopidogrel Versus Ticagrelor in Type-2 Diabetes
- WilL LOWer Dose Aspirin be More Effective Following ACS? (WILLOW-ACS)
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
- The Effect of IV Cangrelor and Oral Ticagrelor Study
- Chewing Versus Traditional Oral Administration of Ticagrelor in STEMI Patients
- High On-treatment Platelet Reactivity Identified by Multiple Platelet Function Assay
- PRotective Effect on the Coronary Microcirculation of Patients With DIabetes by Clopidogrel or Ticagrelor
- The Platelet Aggregation After tiCagrelor Inhibition and FentanYl Trial (PACIFY)
- Ticagrelor Versus Clopidogrel in Carotid Artery Stenting
- Ticagrelor vs Clopidogrel for Platelet Inhibition in Stenting for Cerebral Aneurysm
- Mobilization of Endothelial Progenitor Cells and Aspirin
- Anti-Thrombotic Strategy After Trans-Aortic Valve Implantation for Aortic Stenosis
- A Randomized, Pharmacodynamic Comparison of Low Dose Ticagrelor to Clopidogrel in Patients With Prior Myocardial Infarction
- The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI
- Rapid P2Y12 Receptor Inhibition Attenuates Inflammatory Cell Infiltration in Thrombus Aspirated From the STEMI Patients
- Impact of Morphine Treatment on Platelet Inhibition in Acute Myocardial Infarction
- Optimizing Timing of CABG in Patients Presenting With ACS and Treated With Ticagrelor
- The Effect of Ticagrelor on 15-Epi-Lipoxin A4 and Inflammation
- Comparing Ticagrelor Versus Clopidogrel on Microcirculation
- Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting
- Ticagrelor in Human Endotoxemia Response to Human Endotoxemia
- Comparison of Administration Strategies of Ticagrelor in Patients With Unstable Angina Pectoris, a Pharmacokinetic / Pharmacodynamic Study
- EVOLVE Short DAPT Study
- Comparison of Ticagrelor Pharmacokinetics and Pharmacodynamics in STEMI and NSTEMI Patients
- Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial
- Hunting for the Off-Target Properties of Ticagrelor on Endothelial Function in Humans (HI-TECH)
- The Effect of Ticagrelor or Clopidogrel on Endothelial Function During Acute and Chronic Treatment
- COmparison of the Pharmacodynamics and Pharmacokinetics Ticagrelor Versus Clopidogrel in Patients With CKD and NSTE-ACS
- Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and Ticagrelor
- Impact of Chronic Kidney Disease on the Effects of Ticagrelor in Patients With Diabetes and Coronary Artery Disease
- Platelet Inhibition After Pre-hospital Ticagrelor Using Fentanyl Compared to Morphine in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
- Use of Ticagrelor in Korean ACS Patients: The BRILIANT KOREA Registry
- ComparisoN of ticAgrelor vs. Clopidogrel in endoTHeliAl Function of COPD patieNts
- Ticagrelor Therapy for RefrACTORy Migraine Study
- Safety and Efficacy of Low-dose Ticagrelor in Chinese Patients With Stable Coronary Artery Disease
- Evaluation of Antiplatelet Effects and Safety of Intraoperative Administration of Ticagrelor Versus Clopidogrel
- Ticagrelor vs. Prasugrel Effects on Infarct Size
- Platelet Reactivity in Acute Non-disabling Cerebrovascular Events
- TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement
- Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)
- Comparison of Ticagrelor vs. Prasugrel on Inflammation, Arterial Stiffness, Endothelial Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Coronary Stenting
- Inflammation and Thrombosis in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement (TAVR)
- The Risk of Major Bleeding With Novel Anti-platelets: A Comparison of Ticagrelor With Clopidogrel in a Real World Population of 5000 Patients Treated for Acute Coronary Syndrome
- A Study to Assess the Effect of Ticagrelor in Reducing the Number of Days With Pain in Patients With Sickle Cell Disease
- Peripheral Endothelial Function Assessment of Patients on Ticagrelor vs. Clopidogrel Who Have Undergone PCI
- Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Among CKD and ACS Patients
- Comparison of TIcagrelor and Clopidogrel in Patients With Coronary Artery diseaSe and Type 2 Diabetes Mellitus (TICS-DM)
- Study to Assess the Bioequivalence Between Ticagrelor Orodispersible Tablets and Ticagrelor Immediate-release Tablets in Japanese Subjects
- Dose Adaptation to Offset the Interaction Between Ticagrelor and Ritonavir by Population-based PK Modeling
- A Multicenter Trial to Assess the MIcrovascular Integrity and Left Ventricular Function Recovery After Clopidogrel or TicagrelOr Administration, in Patients With STEMI Treated With Thrombolysis - The 'MIRTOS' Study
- Role of Immune Responses After Acute Myocardial Infarction
- Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor
- Safety and Efficacy of Low-Dose Ticagrelor in Chinese Patients With NSTE-ACS
- Ticagrelor and Peripheral Arterial Disease
- Ticagrelor and Anti-inflammatory Effects
- Brilinta Taiwan Post Approval Safety Study
- Effect of Methylnaltrexone on the PK/PD Profiles of Ticagrelor in Patients Treated With Morphine
- Sub Lingual Versus Traditional Oral Administration of Ticagrelor in Acute Coronary Syndrome/Non ST-elevation Myocardial Infarction - A Platelet Reactivity Study
- Study to Assess the Bioavailability of Ticagrelor OD Tablet vs. IR Tablet
- Genotype and Platelet Reactivity in Patients on Hemodialysis
- Reversal of the Anti-platelet Effects of Ticagrelor
- Effect of Ticagrelor Versus Clopidogrel on Endothelial Dysfunction and Vascular Inflammation
- P3AMI Antiplatelet Trial
- The Effect Of Ticagrelor On Saphenous Vein Graft Patency In Patients Undergoing Coronary Artery Bypass Grafting Surgery
- Effects and Plasma Concentration of Ticagrelor, After Crushed and Non-crushed Intake, After Acute Coronary Syndrome
- Determine the Safety/Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for Hemodialysis
- A Single-center, Prospective,Randomized Study of Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting
- STEEL Percutaneous Coronary Intervention
- Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease Patients With Type 2 Diabetes
- Impact of Renal Function on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients
- Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes
- Ticagrelor or Prasugrel Versus Clopidogrel in Elderly Patients With an Acute Coronary Syndrome and a High Bleeding Risk: Optimization of Antiplatelet Treatment in High-risk Elderly
- Bivalirudin vs Heparin in NSTEMI and STEMI in Patients on Modern Antiplatelet Therapy in SWEDEHEART
- Trial of Caffeine to Alleviate Dyspnea Related to Ticagrelor
- Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtients
- Ticagrelor in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis
- A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
- Ticagrelor Pharmacokinetics in NSTEMI
- Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
- Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease
- High "on Treatment" Platelet Reactivity in the Intensive Care Unit
- Effect of Ticagrelor on Adenosine-Induced Coronary Flow Reserve in Patients With Microvascular Angina
- NIRS Ticagrelor Evaluation
- Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention
- Real Life Long-term Adherence to Ticagrelor After PCI for Acute Coronary Syndromes
- Ticagrelor and Endothelial Function
- Impairment of Gastric Emptying During Acute Phase of Myocardial Infarction. Impact on Oral Antiplatelet Treatment Efficacy. The GASTRIM Study.
- EndoTic - Endothelium and Ticagrelor
- Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI
- Establishing the Microcirculatory Effects of Ticagrelor on Tissue Perfusion in Critical Limb Ischemia
- Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR
- Ticagrelor Versus Clopidogrel in Left Ventricular Remodeling After ST-segment Elevation Myocardial Infarction
- Antiplatelet Therapy After Cardiac Arrest
- Platelet Reactivity After TAVI: A Multicenter Pilot Study
- Arachidonic Acid-induced Platelet Aggregation Rate in Patients With Stable CAD Treated With Ticagrelor Monotherapy
- Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Acute Myocardial Infarction
- Sampling P2Y12 Receptor Inhibition With Prasugrel and Ticagrelor in Patients Submitted to Thrombolysis
- A Pharmacokinetic (PK) and Pharmacodynamic (PD) Dose-ranging Phase II Study of Ticagrelor in Paediatric Patients With Sickle Cell Disease
- Pharmacological Effects of Crushing Prasugrel in STEMI Patients
- TIcaGrEloR and ABSORB Bioresorbable Vascular Scaffold Implantation for Recovery of Vascular Function After Successful Chronic Total Occlusion Recanalization
- Safety of "Ticagrelor+ Warfarin"in Comparison With "Clopidogrel+Aspirin+Warfarin"
- Different Antiplatelet Therapy Strategy After Coronary Artery Bypass Graft Surgery
- Efficacy of Ticagrelor vs Clopidogrel in High-risk NSTE-ACS Patients Undergoing Early PCI
- Reversing Ticagrelor's Effects With Fresh Platelets
- Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients (HOST REDUCE POLYTECH RCT Trial)
- REalWorld Insights on the INitiation and Treatment Duration of ticagrEloR & Other Oral Antiplatelets (OAP) in Patients With Acute Coronary Syndrome (ACS) in Be/Lux.
- Is Efficacy of PLAtelet Aggregation Inhibition by Ticagrelor Mediated P2Y12 Blockade Dependent Upon Endogenous Endothelial Nitric OXide?
- Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)
- ONSET and OFFSET of Ticagrelor in ESRD
- Optical Coherence Tomography to Evaluate Ticagrelor and Clopidogrel
- Comparison of Ticagrelor And Clopidogrel on Inflammatory Biomarkers And Vascular Endothelial Function
- Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease Patients
- The Effect of Clopidogrel and Ticagrelor With and Without Acetylsalicylic Acid (ASA) on Hemostatic System Activation at the Site of Plug Formation in Vivo in Man
- Short-term Dual Anti Platelet Therapy in Patients With ACS Treated With the COMBO Dual-therapy Stent
- DIAMOND - Dual Antiplatelet Therapy to Reduce Myocardial Injury
- Effect of Ticagrelor on Fractional Flow Reserve
- Platelet Reactivity (High On-Treatment Platelet Reactivity) as Guidance for APT (Antiplatelet Therapy) Adjustment After PCI (Percutaneous Coronary Intervention)
- Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management
- Switch to Ticagrelor in Critical Limb Ischemia Anti-platelet Study
- Clopidogrel And Ticagrelor in Healthy Subjects
- In Vitro Pharmacodynamic Effects of Cangrelor in Ticagrelor Treated Patients
- Triple vs. Dual Therapy
- Prasugrel and Ticagrelor in ST-segment Elevation Myocardial Infarction
- Study of Effects of Ticagrelor on Microparticles and Micro-RNA in NSTE-ACS
- Compare Ticagrelor vs Clopidogrel on the Reduction of Arterial Stiffness and Wave Reflectionsin Patients With CAD.
- The Efficacy of Ticagrelor on Abdominal Aortic Aneurysm (AAA) Expansion
- A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients Undergoing PCI With CYP2C19 Loss-of-function:
- Ticagrelor China Pharmacokinetic/Pharmacodynamic Study
- Transition From Ticagrelor to Clopidogrel Following Acute Coronary Syndrome: To Bolus or Not?
- Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis
- Ticagrelor vs Clopidogrel in Non-ST Elevation Acute Coronary Syndrome Patients Undergoing PCI With Bivalirudin.
- Aspirin Impact on Platelet Reactivity in Acute Coronary Syndrome Patients on Novel P2Y12 Inhibitors Therapy
- Genotyping Guided Individualized Treatment of Clopidogrel and Ticagrelor in ACS
- Comparing Ticagrelor and Clopidogrel Pharmacodynamics After Thrombolysis
- OraL Crushed and dIspersed Ticagrelor 180mg Compared to Whole Tablets of eQUal Dose in STEMI Patients unDergoing Primary PCI: a Pharmacokinetic/Pharmacodynamic Study (the LIQUID Study)
- A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding Risk
- Paradigm Shift in the Treatment of Patients With ACS
- Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome
- Assessment of Coronary Flow Reserve by Doppler Flow WIre in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Differences Between the Loading Dose of Prasugrel and Ticagrelor .
- Assessment of Coronary Flow Reserve by Doppler Flow Wire in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Differences Between the Loading Dose of Ticagrelor and Clopidogrel
- "Pharmacodynamic Comparison of Omeprazole Versus Pantoprazole on Platelet Reactivity in Patients With Acute Coronary Syndromes on Dual Antiplatelet Therapy With New P2Y12 Inhibitors" -Trial dOPPLER-
- Comparison of Clopidogrel and Ticagrelor on Microvascular Dysfunction in ST-Segment Elevation Myocardial Infarction
- Pharmacokinetics, Pharmacodynamics, and Safety Study of Ticagrelor in Hemodialysis Patients and Healthy Subjects
- TicAgrelor Versus CLOpidogrel in Stabilized Patients With Acute Myocardial Infarction: TALOS-AMI
- Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor
- Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Angina, NSTEMI and STEMI Undergoing PCI
- Ticagrelor in Severe Community Acquired Pneumonia
- Ticagrelor and Adenosine
- Genotype Guided Versus Conventional Approach in Selection of Oral P2Y12 Receptor Blocker in Chinese Patients Suffering From Acute Coronary Syndrome
- [SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
- Mojito Study (Mashed Or Just Integral Pill of TicagrelOr ? )
- A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus
- Different LD of Ticagrelor for Antiplatelet Effect in Patients With Non-ST-segment Elevation ACS Undergoing PCI
- Ticagrelor Loading Dose Versus Clopidogrel Loading and Reloading With Ticagrelor.
- Differential Effect of Ticagrelor Versus Prasugrel Maintenance Dose on Endothelial Function of Peripheral Vessels in Patients With Coronary Artery Disease
- OPTImal Management of Antithrombotic Agents: OPTIMA-2 Trial
- Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome
- Ticagrelor vs High Dose Clopidogrel in Patients With ST Elevation Myocardial Infarction Post Fibrinolysis
- Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome
- Ticagrelor for PCI Post Thrombolysis
- Ticagrelor and Eptifibatide Bolus-Only Versus Ticagrelor and Eptifibatide Bolus Plus Abbreviated Infusion
- Effect of Pretreatment With Ticagrelor on Residual Thrombus After PCI in Patients Presenting With ACS in Comparison With Delayed Treatment at the Time of PCI: an OCT Study
- Comparison of Clopidogrel Versus Ticagrelor Therapy for Atherosclerotic Plaque Inflammation
- High Ticagrelor Loading Dose in STEMI
- Ticagrelor vs Clopidogrel Effect on MFR in CAD Population
- Study to Investigate if the Uptake of Ticagrelor Into the Body Differs Depending on Method of Administration.
- Targeting Platelet-Leukocyte Aggregates in Pneumonia With Ticagrelor
- PKPD Study of Ticagrelor and Prasugrel in Healthy Korean Males
- Brilinta DaYu Study
- Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy With Ticagrelor
- A Phase IV Study of the Onset and Maintenance of the Antiplatelet Effect of Ticagrelor Compared With Clopidogrel in Chinese Patients With ACS
- Pharmacodynamic Effect of Prasugrel vs. Ticagrelor in Diabetes
- Pharmacodynamic Effects of Prasugrel Compared With Ticagrelor in Patients With Coronary Artery Disease
- The Antiplatelet and Immune Response Trial
- A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention
- The ACS Ethnicity Platelet Function Study
- Comparison of Ticagrelor Versus Clopidogrel on Residual Thrombus Burden During PCI: an OCT Study
- Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients
- Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy
- GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation
- Efficacy and Safety Study of Ticagrelor
- Antithrombotic Triple Therapy in Humans
- Effect of Ticagrelor on Endothelial Function
- Rapid Activity of Platelet Inhibitor Drugs Study 2
- Platelet Aggregation During the Shift From Clopidogrel to Ticagrelor
- Dabigatran Treatment Following Transient Ischemic Attack and Minor Stroke
- Cangrelor Ticagrelor Transition Study
- A Clinical Study of Safety and P2Y12 Receptor Inhibition Effects of Ticagrelor and Clopidogrel in Vietnamese Patient
- Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG
- Study to See if Platelet Transfusion Stop or Lessen the Effect of the Drug on Platelets
- Tailored Antiplatelet Therapy Following PCI
- On-treatment PLAtelet Reactivity-guided Therapy Modification FOR ST-segment Elevation Myocardial Infarction
- Ticagrelor and Intracoronary Morphine in Patients Undergoing Primary Percutaneous Coronary Intervention
- Investigation of Drug-drug Interaction of Dabigatran and Ticagrelor
- A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
- Impact of Ticagrelor Re-load on Pharmacodynamic Profiles
- Antiplatelet Effects of Ticagrelor Versus Clopidogrel in American Indian Patients
- Endothelium, Stenting, and Antiplatelet Therapy (EST) - Clopidogrel, Prasugrel, Ticagrelor Study
- Effect of Ticagrelor vs. Dipyridamole on Adenosine Uptake
- Comparison of Antiplatelet Effect of Ticagrelor vs Tirofiban in Patients With Non-ST Elevation Acute Coronary Syndrome
- Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to Clopidogrel
- Differential Effect of Ticagrelor Versus Prasugrel on the Adenosine-induced Coronary Vasodilatory Responses in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
- Τicagrelor Versus Prasugrel in Diabetic Patients: a Pharmacodynamic Study
- Antithrombotic Effects of Ticagrelor Versus Clopidogrel
- Evaluation of Ticagrelor Anti Platelet and Pleiotropic Effects in Patients Undergoing Percutaneous Coronary Intervention for an Acute Coronary Syndrome
- Ad Hoc Percutaneous Coronary Intervention Study in Acute Coronary Syndrome Patients
- Investigation of Pharmacodynamic Effects of Dabigatran and Ticagrelor and Assessment of Ticagrelor Interaction Potential With Dabigatran
- ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography
- PROMUS Element Plus US Post-Approval Study
- Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
- Standard (180mg) Versus Double (360mg) Loading Dose of Ticagrelor in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)
- High Clopidogrel Dose Versus Prasugrel and Ticagrelor in High Reactive Stable Patients
- PraSugrel vs TicagrElor in ST-Elevation Myocardial Infarction paTients With Diabetes Mellitus
- Study of LC23-1306 in Healthy Male Subjects
- A Pharmacodynamic Study With Ticagrelor in African American Patients
- A Pharmacodynamic Study With Ticagrelor in Hispanic Patients
- How Effective Are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention
- Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry
- Ticagrelor in Clopidogrel Resistant Patients Undergoing Chronic Hemodialysis
- Rapid Activity of Platelet Inhibitor Drugs Study
- Study to Assess Effect of Cyclosporine on the Blood Levels of Ticagrelor
- Ticagrelor in Comparison to Prasugrel for Early Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)
- Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function Testing
- Ticagrelor and Aspirin for the Prevention of Cardiovascular Events After Coronary Artery Bypass Surgery
- Drug Drug Interactions of Aspirin and P2Y12-inhibitors
- Ticagrelor Versus Prasugrel in Acute Coronary Syndromes After Percutaneous Coronary Intervention
- Evaluation of the Drug-drug Interaction Between Ticagrelor and Venlafaxine When Taken Together in Healthy Volunteers
- A 30 Day Study to Evaluate Efficacy and Safety of Pre-hospital vs. In-hospital Initiation of Ticagrelor Therapy in STEMI Patients Planned for Percutaneous Coronary Intervention (PCI)
- Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)
- Extended Drug Utilization Study Among Patients Exposed to Ticagrelor, Clopidogrel and Prasugrel
- Study to Assess the Effect of Ticagrelor on Coronary Blood Flow in Healthy Male Subjects.
- Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
- An Asian Study to Assess the Properties and Profile of Ticagrelor in Patients With Stable Coronary Artery Disease
- European Ambulance Acute Coronary Syndrome (ACS) Angiography Trial
- A Study of the Antiplatelet Effects Comparing Ticagrelor (Ticag. - AZD6140) With Clopidogrel (Clop.) Responder and Non-responders
- A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin
- A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome
Clinical trials list
click for details